ARCHIVES

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

Virus Cancer Program Includes “Some Of The Bes Basic Research Anywhere,” Moloney Says

January 9, 1976

Trial Combines Drugs Against Blood Vessel Formation

October 26, 2007

House, Senate Committee Increase FDA Funding, Drop User Fees

August 4, 1989

NCI Program Review: Report calls For Two Types Of Centers: Comprehensive And All Others

October 18, 1996

Momentum Continues For Private Development Of Free Standing Cancer Centers

July 19, 1985

Resource Offered for DNA Probe Mapping

August 14, 1987